-
Session to address the economic and health value of obesity treatment
Panelists, including Tim Dall, MS, will help make business and social cases for investing in evidence-based treatment for obesity, such as lower healthcare costs, improved quality of life, and reduced mortality.
-
2026 Scientific Sessions opens four days of discovery
Jazz medleys, greetings from the American Diabetes Association® chief executive officer, an address on the future of diabetes research from a senior advisor at the National Institutes of Health, and highlights of cutting-edge science from ADA Pathway scientists marked the opening of the 2026 Scientific Sessions in New Orleans.
-
Diabetes Journal symposium to explore non-classical complications of diabetes
Norbert Stefan, MD, PhD, and three other panelists will present the latest findings on how complications such as metabolic dysfunction-associated steatotic liver disease (MASLD), infections, cancer, and diastolic dysfunction are impacting individuals living with diabetes.
-
Authors to explain updates to new consensus statement on managing hyperglycemia in type 2 diabetes
Jennifer Green, MD, and others involved in updating the guidance from the ADA and the European Association for the Study of Diabetes, will discuss the rationale behind the shifting emphasis on assessing and changing behaviors and medications to improve outcomes over a person’s lifespan.
-
Panelists to outline impact of youth substance use on diabetes care
Elissa Weitzman, ScD, MSc, will be part of a trio of presenters in an Ask the Experts session focused on how to integrate conversations about the use of tobacco, alcohol, cannabis, pain medications, and other substances into clinical care for young people living with diabetes.
-
Panel to review the impact of disordered eating in diabetes and obesity
Nicole Patience, MS, RDN, LDN, CEDS-C, CDCES, and other experts will explain how eating disorders and imbalanced eating can affect people living with diabetes or obesity and how to help them achieve sustainable wellness.
-
Symposium to examine AI’s current and near-future impact on diabetes tech
Boris Kovatchev, PhD, and other panelists will share recent developments in the application of artificial intelligence in automated insulin delivery, clinical decision-making, nutrition estimation, diabetes coaching, and more.
-
Innovation Challenge to pitch groundbreaking projects for diabetes
The Innovation Challenge returns with live presentations on Saturday from five emerging companies developing game-changing solutions to real-world problems affecting people living with diabetes, their family members, or caregivers.
-
ADA Scholars program provides immersive professional development
Over two days, 70 early-career ADA Scholars convened for a unique opportunity to engage with peers and senior leaders while participating in programming designed to support their career growth at a pivotal stage.
-
Welcome to New Orleans for the Scientific Sessions
The dynamic four-day program developed by this year’s Scientific Sessions Planning Committee is packed with scientific discovery, clinical innovation, networking channels, and more for researchers and healthcare professionals dedicated to advancing the prevention, treatment, care, and the long-sought cure for diabetes.